Inhibikase Therapeutics I... (IKT)
NASDAQ: IKT
· Real-Time Price · USD
1.67
-0.04 (-2.34%)
At close: Sep 05, 2025, 3:59 PM
1.67
0.00%
After-hours: Sep 05, 2025, 04:41 PM EDT
Inhibikase Therapeutics Revenue
Inhibikase Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending June 30, 2025, Inhibikase Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
0
Employees
15
Market Cap
124.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | -100.00% |
| Dec 31, 2023 | 260.5K | +111.03% |
| Dec 31, 2022 | 123.44K | -96.02% |
| Dec 31, 2021 | 3.1M | +343.92% |
| Dec 31, 2020 | 698.47K | -37.79% |
| Dec 31, 2019 | 1.12M | -72.22% |
| Dec 31, 2018 | 4.04M | +96.07% |
| Dec 31, 2017 | 2.06M | +113.04% |
| Dec 31, 2016 | 967.39K | n/a |